Cancer-cell-intrinsic mechanisms shaping the immunosuppressive landscape of prostate cancer
Although immunotherapy has revolutionized cancer treatment and achieved remarkable success across many different cancer types, only a subset of patients shows meaningful clinical responses. In particular, advanced prostate cancer exhibits overwhelming de novo resistance to immune checkpoint blockade...
Main Authors: | Yini Zhu, Loan Duong, Xuemin Lu, Xin Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Asian Journal of Andrology |
Subjects: | |
Online Access: | http://www.ajandrology.com/article.asp?issn=1008-682X;year=2023;volume=25;issue=2;spage=171;epage=178;aulast=Zhu |
Similar Items
-
The Immunotherapy and Immunosuppressive Signaling in Therapy-Resistant Prostate Cancer
by: Pengfei Xu, et al.
Published: (2022-07-01) -
The Current Therapeutic Landscape for Metastatic Prostate Cancer
by: Anastasia Bernal, et al.
Published: (2024-03-01) -
Myeloid-Derived Suppressor Cells in Prostate Cancer: Present Knowledge and Future Perspectives
by: Filippos Koinis, et al.
Published: (2021-12-01) -
Immunotherapy in Prostate Cancer
by: Emily K. Fay, et al.
Published: (2020-07-01) -
Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation
by: Lina Merkens, et al.
Published: (2022-02-01)